Heart News and Research

RSS

Salt substitute use remains low among Americans with high blood pressure

Few people with high blood pressure were using salt substitutes, even though they are a simple and effective way to lower sodium intake and manage blood pressure, according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2025.

4 Sep 2025

New study explores how childhood social determinants impact young adult cardiovascular health

Cardiovascular disease (CVD) remains the leading cause of death and disability for adults in the U.S. Recent projections from the American Heart Association suggest that by 2050, more than 45 million American adults will have clinical CVD and more than 184 million will have hypertension.

4 Sep 2025

No advantage found in modulating antiplatelet therapy intensity after complex stenting

There was no benefit to modulating the intensity of antiplatelet therapy compared with standard antiplatelet therapy in high-risk patients who had undergone complex stenting procedures, according to late-breaking research presented in a Hot Line session today at ESC Congress 2025.

4 Sep 2025

Intense light therapy boosts heart protection after surgery

Intense light therapy after surgery can increase a critical protein that protects heart tissue while lowering levels of troponin, a protein indicating heart damage that's linked to higher mortality in patients undergoing non-cardiac surgery, according to a study by researchers at CU Anschutz.

4 Sep 2025

Neutrophil peptide found to trigger dangerous heart arrhythmias

Following injury from a heart attack, immune cells called neutrophils release a peptide that punctures stressed heart cells and destabilizes their electrical activity.

4 Sep 2025

Single antibody causes a rare but dangerous reaction to widely-used blood thinner

Researchers at McMaster University have discovered that a rare but dangerous reaction to a widely used blood thinner is caused by a single antibody – overturning decades of medical misunderstanding and opening the door to more precise ways of diagnosing and treating this medical complication.

3 Sep 2025

Living in food deserts linked to higher stroke and death risk in atrial fibrillation patients

Patients with atrial fibrillation who live in neighborhoods with poor access to full-service grocery stores face sharply higher odds of stroke and death, according to a new study from Tulane University.

3 Sep 2025

Study finds universal rise in cholesterol after menopause among Bolivian Tsimane women

Deep in the Bolivian Amazon exists a forager-horticultural community called the Tsimane. Researchers look to them for insights on how the human body functioned prior to modern technologies, as their lifestyles remain the closest to that of our ancestors.

3 Sep 2025

Dual antiplatelet therapy shows no benefit over aspirin after CABG in patients with acute coronary syndrome

Dual antiplatelet therapy (DAPT) was not more effective than aspirin alone for the prevention of major adverse cardiovascular events and increased major bleeding in patients with acute coronary syndrome (ACS) who underwent coronary artery bypass grafting (CABG), according to late-breaking research presented in a Hot Line session today at ESC Congress 20251 and simultaneously published in New England Journal of Medicine.

3 Sep 2025

Stopping oral anticoagulation reduces risk after successful atrial fibrillation ablation

Discontinuing oral anticoagulation (OAC) therapy resulted in a lower risk of a composite of stroke, systemic embolism or major bleeding than continuing OAC therapy in patients who had successful ablation for atrial fibrillation at least 12 months previously, according to results from a late-breaking trial presented in a Hot Line session today at ESC Congress 2025 and simultaneously published in The Journal of the American Medical Association.

3 Sep 2025

Reconditioned pacemakers show comparable infection rates to new devices

Procedure-related infection rates were similar with reconditioned and new pacemakers, according to late-breaking research presented in a Hot Line session today at ESC Congress 2025.

3 Sep 2025

Sacubitril/valsartan shows benefit over enalapril in heart failure caused by Chagas disease

In patients with heart failure (HF) caused by Chagas disease, sacubitril/valsartan was superior to enalapril for the composite primary endpoint, predominantly driven by a significant reduction in N-terminal pro-B-type natriuretic peptide (NT-proBNP), according to late-breaking research presented in a Hot Line session today at ESC Congress 2025.

3 Sep 2025

Long-term benzodiazepine use linked to poor sleep quality in older adults

Long-term use of benzodiazepine and related drugs has been linked to poorer quality sleep in older adults with insomnia.

3 Sep 2025

Flooding from Hurricane Sandy raises heart disease risk years later

Although the material damage from 2012's Hurricane Sandy may have been repaired, the storm left a lasting impact on cardiovascular health, according to new findings from Weill Cornell Medicine and New York University researchers.

3 Sep 2025

Researchers uncover a promising new therapeutic target for Barth syndrome

Researchers at The Hospital for Sick Children (SickKids) have uncovered a promising new therapeutic target for Barth syndrome, a rare genetic condition with no current cure.

3 Sep 2025

Intravenous cangrelor provides rapid platelet inhibition in cardiogenic shock

Compared with crushed ticagrelor, intravenous cangrelor provided immediate, effective platelet inhibition, with no increase in major bleeding and lower mortality rates in patients with acute myocardial infarction and cardiogenic shock, according to late-breaking research presented in a Hot Line session today at ESC Congress 2025.

3 Sep 2025

Home-based hypertension care improves blood pressure control in rural South Africa

Home-based hypertension care led to reductions in systolic blood pressure and improvements in hypertension control in South Africa, according to late-breaking research presented in a Hot Line session today at ESC Congress 2025 and simultaneously published in the New England Journal of Medicine.

3 Sep 2025

Novel ablation approach improves outcomes in patients with persistent atrial fibrillation

Adding digital twin-guided ablation to a standard ablation technique improved outcomes in patients with persistent atrial fibrillation (AF), according to late-breaking research presented in a Hot Line session today at ESC Congress 2025.

3 Sep 2025

At CDC, worries mount that agency has taken anti-science turn

Public health and access to lifesaving vaccines are on the line in a high-stakes leadership battle at the Centers for Disease Control and Prevention.

3 Sep 2025

Qureight appoints Craig Rhodes as Head of Partnerships to lead on pharma relationship management

Qureight, a techbio company advancing the understanding of lung and heart disease through application of its AI-powered imaging and clinical data curation platform, today announced the appointment of Craig Rhodes as Head of Partnerships to lead strategic engagements with pharmaceutical organizations, in line with Qureight’s revenue growth targets.

From Qureight 3 Sep 2025

Heart News and Research

Salt substitute use remains low among Americans with high blood pressure

New study explores how childhood social determinants impact young adult cardiovascular health

No advantage found in modulating antiplatelet therapy intensity after complex stenting

Intense light therapy boosts heart protection after surgery

Neutrophil peptide found to trigger dangerous heart arrhythmias

Single antibody causes a rare but dangerous reaction to widely-used blood thinner

Living in food deserts linked to higher stroke and death risk in atrial fibrillation patients

Study finds universal rise in cholesterol after menopause among Bolivian Tsimane women

Dual antiplatelet therapy shows no benefit over aspirin after CABG in patients with acute coronary syndrome

Stopping oral anticoagulation reduces risk after successful atrial fibrillation ablation

Reconditioned pacemakers show comparable infection rates to new devices

Sacubitril/valsartan shows benefit over enalapril in heart failure caused by Chagas disease

Long-term benzodiazepine use linked to poor sleep quality in older adults

Flooding from Hurricane Sandy raises heart disease risk years later

Researchers uncover a promising new therapeutic target for Barth syndrome

Intravenous cangrelor provides rapid platelet inhibition in cardiogenic shock

Home-based hypertension care improves blood pressure control in rural South Africa

Novel ablation approach improves outcomes in patients with persistent atrial fibrillation

At CDC, worries mount that agency has taken anti-science turn

Qureight appoints Craig Rhodes as Head of Partnerships to lead on pharma relationship management

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News